Dr Violeta M Manansala, MD | |
982 Tiogue Ave, Coventry, RI 02816-6167 | |
(401) 821-6800 | |
Not Available |
Full Name | Dr Violeta M Manansala |
---|---|
Gender | Female |
Speciality | Radiology - Diagnostic Radiology |
Location | 982 Tiogue Ave, Coventry, Rhode Island |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1114060431 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2085R0202X | Radiology - Diagnostic Radiology | MD05111 (Rhode Island) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Violeta M Manansala, MD 8 Quail Ct, East Greenwich, RI 02818-1569 Ph: (401) 885-6717 | Dr Violeta M Manansala, MD 982 Tiogue Ave, Coventry, RI 02816-6167 Ph: (401) 821-6800 |
News Archive
A team of scientists, led by Napoleone Ferrara, MD, has shown for the first time that a signaling protein involved in inflammation also promotes tumor resistance to anti-angiogenic therapy.
A new study released by the New England Journal of Medicine found that among patients with non-small-cell lung cancer, those who received palliative care lived, on average, almost two months longer than those who received standard care. Researchers also found that the patients receiving palliative care reported a higher quality of life through the final course of their illness.
LUNGevity Foundation, the nation's leading lung cancer nonprofit, applauds the Food and Drug Administration's approval of Bristol Myers Squibb's new immunotherapy drug Opdivo (nivolumab). Opdivo and other immunotherapy treatments add another critical new treatment option to fight lung cancer by harnessing the power of a patient's own immune system to fight cancerous cells.
The National Comprehensive Cancer Network and Proventys, a leader in advanced decision support technologies, have entered into an exclusive collaboration to introduce the Proventys CDS Oncology system, a first-of-its-kind Web platform that arms oncologists with expert recommendations and evidence facilitating the delivery of high-quality, individualized patient care.
› Verified 3 days ago